Peter Attia· MD
let's talk about the fibrates and then obviously want to talk about niacin through a clinical trial standpoint and then we'll get into the pcsk9 so we'll take a break right now and we will come back okay guys so we are now back we're going to slice this beginning into where we finished off so we had sort of more or less finished talking about ezetimibe also known as zetia so we use this an opportunity to go into the next drug so alright so Tom that was pretty pretty insightful stuff on zetia also known as ezetimibe let's move to another class of drugs that doesn't get a lot of use I can probably count on two hands the number of times I've prescribed it which is Fenna fibrate or more broadly its classify braids